coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    The Marsh PCN, Folkestone and Hythe · Health Inequalities Profile

    PCN U22192 · NHS Kent and Medway Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    17,904

    Registered population

    50.1% aged 18–64

    35.8%

    Aged 65+

    ICB 19.9% · England 17.9%

    2.2%

    Ethnic minority (non-White)

    0.8% Asian · England 9.6%

    15.9%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~2,536

    Core20 residents (est.)

    Resident basis; registered basis ~2,567 · see page 3

    4,320

    Hypertension register

    +5.25% in 3 yrs · England +5.60%

    195

    SMI register

    13.8% of Folkestone and Hythe's

    775

    COPD register

    Reviews -9.38% in 3 yrs

    Forecast to 2030

    4,927

    Hypertension patients, 2030

    +607 on today

    71.1%

    QRISK ≥20% on statins, 2030

    +4.20pp over 3 yrs

    8.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    50.7%
    Asthma annual reviews trail England.

    Only 50.7% of asthma patients had an annual review (England 65.7%, ICB 60.4%), leaving about 620 of 1,252 patients unreviewed.

    70.1%
    SMI blood pressure checks fell and lag.

    SMI blood pressure checks stand at 70.1% (England 83.4%, ICB 79.7%), falling 2.7 pp over 2023 to 2025 while England rose +4.4 pp.

    +17.5%
    Under-80 hypertension BP control improved faster.

    Under-80 hypertension blood pressure control rose +17.5% over 2023 to 2025 (England +3.2%), and overall treatment to target grew +10.9% (England +3.6%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    At 35.8%, registered patients aged 65+ substantially exceed England's 17.9%

    The Marsh PCN cares for 17,904 registered patients across three practices. Of these, 35.8% (6,403 patients) are aged 65+, markedly higher than Folkestone and Hythe (25.7%), NHS Kent and Medway ICB (19.9%), and England (17.9%). Conversely, 14.1% (2,532 patients) are aged 0-17, below the borough (17.4%), ICB (20.7%), and England (19.6%). Census data indicates 97.8% of local residents are White, compared with 92.6% in Folkestone and Hythe, 88.6% in the ICB, and 81.1% nationally (2.2% non-White ethnic minority share). Ethnicity reflects Census usual residents, not registered patients.

    Age profile

    0–1714.1%
    18–6450.1%
    65+35.8%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White97.8%
    Mixed1.0%
    Asian0.8%
    Other0.2%
    Black0.2%

    Older people · falls rows are Folkestone and Hythe local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Folkestone & Hythe LA)1,6992,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.2%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.6%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Folkestone & Hythe LA)8569819552024/25
    Falls deaths, all ages, per 100,000 (Folkestone & Hythe LA)16.014.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    PCN Core20 share is 15.9% but spans 21.3 percentage points across practices

    PCN Core20 share is 15.9%, below Folkestone and Hythe (21.7%), NHS Kent and Medway ICB (17.1%) and England (21.0%), with an average IMD decile of 3.8 (England 5.5). Deprivation is polarised across practices: a 21.3 pp spread divides Oak Hall (21.3%, 1,276 estimated patients) and Church Lane Health Centre (20.1%, 1,291 estimated patients) from Martello Health Centre (0.0%). The weighted practice Core20 share is 14.3%, differing by 1.56 percentage points from the PCN figure. This concentration points to focusing deprivation-linked outreach in the two affected practices.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Oak Hall21.3% · 1,276 patients
    Church Lane20.1% · 1,291 patients
    Martello0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    195

    SMI register

    1.10% recorded prevalence

    209

    Learning disability register

    1.18% recorded prevalence

    21

    Care homes, 320 beds

    In the PCN catchment

    10.2%

    Provide unpaid care

    Folkestone and Hythe, Census 2021

    The PCN records 209 learning disability patients (1.2% prevalence; Folkestone and Hythe 0.9%, ICB 0.6%, England 0.6%) and 195 with severe mental illness (1.1%; England 1.0%). Catchment care homes total 21 (320 beds), though bed capacity does not establish registered patient residence. Higher recorded learning disability prevalence may indicate greater need for annual health checks across member practices.

    Severe mental illness: physical health checks

    SMI physical health checks trail benchmarks: 70.1% had a blood pressure check (England 83.4%), falling 2.7 pp over 2023 to 2025 (England +4.4 pp), and 70.1% had a BMI record (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,320

    Hypertension register

    +5.25%

    Register growth, 3 yrs

    Folkestone and Hythe +5.18% · England +5.60%

    +9.80pp

    BP control, under 80

    ≤140/90 · +6.08pp aged 80+

    +607

    More patients by 2030

    Forecast 4,927 (27.08%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 24.4% across 4,320 patients, above England (15.2%), Folkestone and Hythe (18.6%) and the ICB (16.2%). While blood pressure control for patients under 80 rose +17.5% over 2023 to 2025 (England +3.2%), current control is 65.8% (England 67.8%). Control for patients aged 80 and over is 76.5% (England 81.2%), and is 69.5% at Martello Health Centre. Overall treatment to target is 66.6% (England 70.3%). Lower control rates than England across older hypertensive cohorts suggest an opportunity to prioritise systematic blood pressure review and treatment optimisation.

    Lipids and statins

    Lipid-lowering therapy reaches 61.7% of patients with QRISK ≥ 20% (England 63.6%) and 65.8% of CKD patients (England 70.3%). Statin treatment for diabetic patients without prior cardiovascular disease is 69.6% (England 73.2%). Fewer at-risk patients receive lipid coverage than England rates imply, highlighting an opportunity to prioritise targeted statin reviews.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202637,646£2.70£1.90£1.86£101,644
    Cardiovascular (all), 202554,290£4.02£3.57£3.33£218,246

    In 2026, the PCN prescribed 37,646 lipid-regulating items at £2.70 per item, exceeding England (£1.86), Folkestone and Hythe (£2.17) and the ICB (£1.90). This represents £31,623 more than at England's unit cost across 37,646 items. Prescribing unit costs exceeding ICB and national benchmarks indicate an opportunity to prioritise lipid-modifying formulary reviews.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +8.84%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.21%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.4% (England 6.6%), yet annual reviews reach 50.7% (England 65.7%), leaving about 620 of 1,252 patients unreviewed. Prescribing for ages 5-19 reaches 2,934 items per 1,000 (England 1,488 rate), while second-hand smoke status recording is 61.8% (England 78.8%). Alongside this, COPD prevalence is 4.4% (England 1.9%) across 775 patients, but reviews fell 9.4% over 2023 to 2025 (England +2.8%) to 69.8% (England 76.4%).

    Cancer register and children's immunisation

    Cancer register prevalence is 6.9% across 1,219 patients, above England (3.8%) and the ICB (4.4%). In Q1 2025/26, 6-in-1 coverage at 12 months reached 100.0% (England 91.0%). At age 5, MMR dose 1 coverage is 96.4% while dose 2 is 85.7% (England 82.8%, a 10.7 pp dose difference), and 4-in-1 booster coverage is 85.7% (England 80.9%), both below the 95.0% target by 9.3 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months100.0%

    England 91.0%

    6-in-1 complete primary course at 24 months95.5%

    England 92.2%

    MMR dose 1 at 24 months90.9%

    England 88.3%

    MMR dose 2 at age 585.7%

    England 82.8%

    4-in-1 pre-school booster at age 585.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    Across NHS Kent and Medway ICB in 2022, 55.6% of cancers with a known stage (4,661 of 8,384 cases) were diagnosed at stage 1 or 2, in line with England (55.3%) but 19.4 pp below the 75.0% national ambition. Reaching 75.0% would require about 1,630 extra early-stage diagnoses annually across the ICB, where staging data was recorded for 63.6% of all registered cancers (England 67.0%). Within The Marsh PCN, recorded cancer prevalence is 6.9% (1,219 patients), while cervical screening coverage is 70.3% (England 66.8%) and breast screening is 70.5% (England 69.9%). Sustaining primary care screening uptake and proactive safety-netting remains essential to support earlier-stage diagnosis across the system.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, East Kent Hospitals University NHS Foundation Trust achieved 96.7% on the 31-day cancer standard (standard 96.0%, ICB 95.8%, England 92.5%), but lagged standards for 62-day referral to treatment at 70.0% (standard 85.0%, ICB 75.9%, England 71.2%) and 28-day faster diagnosis at 71.3% (standard 75.0%, ICB 76.8%, England 79.3%). For diagnostics, 48.4% of patients waited 6+ weeks at East Kent Hospitals (England 23.1%; Maidstone and Tunbridge Wells NHS Trust 6.4%), including non-obstetric ultrasound (63.0%) and MRI (47.6%). Prolonged secondary care diagnostic waits may extend time to treatment for patients referred on urgent cancer pathways.

    Pathways within standard (%)East KentEast Sussex HealthcareMaidstone and Tunbridge WellsKent and Medway ICBEngland
    28-day faster diagnosis (75%)71.2884.2081.7876.7879.32
    31-day treatment (96%)96.6798.1998.3595.8492.50
    62-day referral to treatment (85%)70.0167.0487.4375.9371.16
    Diagnostic waits over 6 weeks (%)East KentEast Sussex HealthcareMaidstone and Tunbridge WellsEngland
    MRI47.586.480.9221.40
    CT37.450.480.519.92
    Echocardiography14.1721.942.5728.48
    Colonoscopy9.580.7419.8030.83
    Gastroscopy22.160.3124.0329.02
    All 15 DM01 tests48.385.276.4223.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In Jun 2026, 265,905 provisional community care activities were recorded for Kent residents and 297,595 across NHS Kent and Medway Integrated Care Board. Contacts with adults aged 65+ comprised 65.8% of borough residents' community contacts (138,250 of 210,170). Older residents rely heavily on community services alongside PCN long-term condition management.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 21.0 pp and vaccination achievement spans 56.2 pp across practices

    In 2025/26, clinical QOF achievement was high across all three practices: 97.0% at Church Lane Health Centre, 98.1% at Martello Health Centre, and 99.2% at Oak Hall (England 97.1%). However, vaccination and immunisation achievement spanned 56.2 pp, ranging from 87.0% at Church Lane Health Centre to 53.0% at Martello Health Centre and 30.8% at Oak Hall.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Oak Hall12521.366.9%75.3%81.8%
    Martello1100.058.7%79.0%73.8%
    Church Lane11920.145.8%61.6%55.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNFolkestone and HytheAssetPCNFolkestone and Hythe
    Care homes (catchment)21 (320 beds)n/aSchools (catchment)15n/a
    Children's centres38Places of worship2178
    Libraries28Food banks (VCS)n/a1
    Day centres (VCS)n/a2Children and young people (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)221
    Primary academies415Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured respiratory and heart failure recall

    Asthma reviews reach 50.7% of 1,252 patients (England 65.7%, leaving about 620 unreviewed); COPD fell 9.4% to 69.8% of 775 (England 76.4%, +2.8%); heart failure fell 8.1% to 73.6% of 330 (England 78.5%, +8.7%). For discussion: introduce a single recall template and combined review clinics, starting in the Core20 practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Combined SMI physical health check outreach

    Across 195 SMI patients, annual blood pressure checks are 70.1% (England 83.4%, ICB 79.7%), falling 2.7 pp over 2023 to 2025 (England +4.4 pp); BMI recording is 70.1% (England 82.1%) and alcohol recording is 71.3% (England 81.8%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Hypertension target and lipid formulary review

    Across 4,320 hypertensive patients, treatment to target is 66.6% (England 70.3%) and 80+ control is 76.5% (England 81.2%). QRISK >= 20% lipid therapy is 61.7% (England 63.6%), while 37,646 lipid-modifying items cost £2.70 per item (£31,623 more than at England's £1.86 unit cost). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult proactive care (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Age five booster catch up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Screening recall and safety netting (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Primary care phone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured respiratory and heart failure recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Combined SMI physical health check outreach (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Option 3 · Hypertension target and lipid formulary review (p12)Hypertension register · Hypertension patients treated to target · Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15